• Towards a world without Crohn's disease in the INTERCEPT study: a look into this large-scale clinical trial
    Towards a world without Crohn's disease in the INTERCEPT study: a look into this large-scale clinical trial Stomach ache, fatigue and worrying about where the closest bathroom is located. For many Crohn’s disease patients, this is an everyday reality. “We would like to identify patients earlier, so we can start treatment early and prevent severe symptoms, and maybe one day prevent Crohn’s disease from happening."
  • What actually is the Emma Center for Personalized Medicine?
    What actually is the Emma Center for Personalized Medicine? At the Emma Center for Personalized Medicine (Emma CPM), they accelerate the development, application, and evaluation of therapies for individuals with rare genetic diseases through a tailored approach.
  • Vidi grant for an AGEM researcher
    Vidi grant for an AGEM researcher The Dutch Research Council (NWO) has awarded Vidi grants to 149 promising researchers from across all scientific disciplines, including one AGEM researcher. Each researcher is awarded a maximum of 850,000 euros which enables them to further develop their own research ideas. Congratulations to Tim de Meij on receiving this grant!

Subscribe to our Newsletter

Subscribe to our Newsletter

All news from AGEM